Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kairos Pharma (KAPA) Shares Outstanding (2024 - 2025)

Kairos Pharma's Shares Outstanding history spans 2 years, with the latest figure at $20.8 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 51.58% year-over-year to $20.8 million; the TTM value through Dec 2025 reached $20.8 million, up 51.58%, while the annual FY2025 figure was $20.8 million, 51.58% up from the prior year.
  • Shares Outstanding reached $20.8 million in Q4 2025 per KAPA's latest filing, up from $17.7 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $20.8 million in Q4 2025 to a low of $10.6 million in Q1 2024.